Nachrichten und Videos - MEDTRONIC PLC.

Medtronic announces cash dividend for fourth quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, March 6, 2025 GALWAY , Ireland , March 6, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 6, 2025, approved the company's cash dividend for the fourth quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of...

Medtronic Malaysia and Malaysian Society of Colorectal Surgeons sign MOU to enhance medical training and education programs PR Newswire KUALA LUMPUR, Malaysia, Feb. 25, 2025 KUALA LUMPUR, Malaysia , Feb. 25, 2025 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to jointly organize surgical workshops aimed at enhancing the skills of...

Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's PR Newswire GALWAY, Ireland, Feb. 24, 2025 New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States 1 , Medtronic plc (NYSE:MDT), a global...

Medtronic reports third quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Feb. 18, 2025 Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025 . Key Highlights Revenue of $8.3 billion increased...

Medtronic reports third quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Feb. 18, 2025 Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland , Feb. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its third quarter (Q3) of fiscal year 2025 (FY25), which ended January 24, 2025 . Key Highlights Revenue of $8.3 billion increased...

Medtronic to announce financial results for its third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Feb. 6, 2025 GALWAY , Ireland , Feb. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025 . A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at...

Medtronic to announce financial results for its third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Feb. 5, 2025 GALWAY , Ireland , Feb. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025 . A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at...

Medtronic appoints Thierry Piéton as Chief Financial Officer PR Newswire GALWAY, Ireland, Jan. 21, 2025 GALWAY , Ireland , Jan. 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Thierry Piéton has been appointed Chief Financial Officer for the company, effective March 3, 2025 . He will report to Medtronic Chairman and Chief Executive Officer Geoff Martha and will join the Medtronic Executive Committee. Piéton joins Medtronic...

Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System PR Newswire GALWAY, Ireland, Jan. 13, 2025 National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term data from the SPYRAL-HTN global clinical program GALWAY, Ireland , Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology PR Newswire GALWAY, Ireland, Jan. 13, 2025 European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY, Ireland , Jan. 13, 2025 /PRNewswire/...

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire GALWAY, Ireland, Jan. 7, 2025 GALWAY , Ireland , Jan. 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025 . Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company...

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire GALWAY, Ireland, Jan. 6, 2025 GALWAY , Ireland , Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025 . Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company...

Medtronic announces cash dividend for third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Dec. 5, 2024 GALWAY , Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of...

NORTHAMPTON, MA / ACCESSWIRE / November 21, 2024 / By Ken Washington, Chief Technology and Innovation Officer, and Raman Venkatesh, Chief Sustainability Officer, Medtronic When you think about healthcare technology, you may imagine the pacemaker assisting your dad's ailing heart, the sutures your child received after a bike accident, or the pulse oximeter placed on your finger during your annual physical exam. You probably don't think about the energy or resources required to manufacture those...

Medtronic receives FDA clearance for new InPen™ app, paving the way for its Smart MDI system launch with Simplera™ CGM PR Newswire GALWAY, Ireland, Nov. 20, 2024 New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland , Nov. 20, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug...

NORTHAMPTON, MA / ACCESSWIRE / November 20, 2024 / Medtronic: Medtronic releases 2024 Impact Report highlighting success in healthcare equity with new data from the Healthy Neighbor program, in addition to community engagement and environmental sustainability progress November 20, 2024 /3BL/ - Medtronic plc, a global leader in healthcare technology, has today released its fiscal year 2024 (FY24) Impact Report. The report highlights the company's continued commitment to advancing health equity,...

Medtronic reports second quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Nov. 19, 2024 Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland , Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October...

Medtronic reports second quarter fiscal 2025 financial results PR Newswire GALWAY, Ireland, Nov. 19, 2024 Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation GALWAY, Ireland , Nov. 19, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced financial results for its second quarter (Q2) of fiscal year 2025 (FY25), which ended October...

Ping An Health and Medtronic Form Strategic Partnership at the China International Import Expo (CIIE) PR Newswire HONG KONG and SHANGHAI, Nov. 7, 2024 HONG KONG and SHANGHAI , Nov. 7, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (" Ping An Good Doctor ", "Ping An Health", or "the Company", Stock Code: 1833.HK) established a strategic partnership with Medtronic ( Shanghai ) Management Co., Ltd. ("Medtronic") at the 7th China International Import Expo (CIIE) held at the...

Medtronic to announce financial results for its second quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Nov. 6, 2024 GALWAY , Ireland , Nov. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024 . A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at...